Geneva, April 28 -- International Clinical Trials Registry received information related to the study (ChiCTR2600122363) titled 'A Preliminary Study on the Effect and Safety of Kaixinji Probiotic Powder on Improving Mood in Individuals with Depression and Anxiety' on April 13.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: Wuxi No.2 People's Hospital
Condition:
Moderate to mild depression, moderate to mild anxiety
Intervention:
Control Group:placebo
Recruitment Status: Not Recruiting
Phase: 4
Date of First Enrollment: 2026-04-13
Target Sample Size: Control Group:5;Experimental Group:5;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=317952
Publish...